SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 11:55 am Purchase |
2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
SUVRETTA CAPITAL MANAGEMENT, LLC | 716,759 9.900% |
366,333 (+104.54%) |
Filing |
| 2023-02-13 10:27 am Purchase |
2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
SUVRETTA CAPITAL MANAGEMENT, LLC | 350,426 5.100% |
36,246 (+11.54%) |
Filing |
| 2022-06-13 4:32 pm Purchase |
2022-06-03 | 13G | Kezar Life Sciences, Inc. KZR |
SUVRETTA CAPITAL MANAGEMENT, LLC | 314,180 5.200% |
314,180 (New Position) |
Filing |